AbbVie Just Won FDA Approval for a Once-Daily Parkinson's Pill. Here's Why It Matters More Than You ...

AbbVie Just Won FDA Approval for a Once-Daily Parkinson's Pill. Here's Why It Matters More Than You Think. The drug could eventually generate more than $1 billion annually. Once-daily dosing could help the drug gain patient adoption.